Press Releases

Xias Bio Limited raises £3.8M in Series Seed Funding to disrupt the protein-based ingredients market.

Published On: 04 September 2024

Contact Us

Xias Bio design, manufacture and supply high performance multifunction active proteins. A sustainable alternative to any single function animal derived or recombinant protein.

Press Release

Press Releases

Xias Bio Limited raises £3.8M in Series Seed Funding to disrupt the protein-based ingredients market.

Contact Us

CONTACT Us

FOLLOW US